These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 35968708)

  • 1. Determining coronavirus disease 2019 (COVID-19) community incidence threshold for preoperative testing.
    Zhou J; Wituik C; Al-Salem M; Aljarbou A; Dekker J; Karimi S; Mertz D
    Infect Control Hosp Epidemiol; 2023 Jul; 44(7):1196-1198. PubMed ID: 35968708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Broad respiratory testing to identify SARS-CoV-2 viral co-circulation and inform diagnostic stewardship in the COVID-19 pandemic.
    Marshall NC; Kariyawasam RM; Zelyas N; Kanji JN; Diggle MA
    Virol J; 2021 May; 18(1):93. PubMed ID: 33933115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2 Emergence Amidst Community-Acquired Respiratory Viruses.
    Leuzinger K; Roloff T; Gosert R; Sogaard K; Naegele K; Rentsch K; Bingisser R; Nickel CH; Pargger H; Bassetti S; Bielicki J; Khanna N; Tschudin Sutter S; Widmer A; Hinic V; Battegay M; Egli A; Hirsch HH
    J Infect Dis; 2020 Sep; 222(8):1270-1279. PubMed ID: 32726441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk-based decision-making related to preprocedural coronavirus disease 2019 testing in the setting of GI endoscopy: management of risks, evidence, and behavioral health economics.
    Moy N; Dulleck U; Shah A; Messmann H; Thrift AP; Talley NJ; Holtmann GJ
    Gastrointest Endosc; 2022 Nov; 96(5):735-742.e3. PubMed ID: 35690149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Universal Admission Screening for SARS-CoV-2 Infections among Hospitalized Patients, Switzerland, 2020.
    Scheier T; Schibli A; Eich G; Rüegg C; Kube F; Schmid A; Karrer U; Wolfensberger A; Sax H; Schreiber PW
    Emerg Infect Dis; 2021 Feb; 27(2):404-410. PubMed ID: 33395382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early trends for SARS-CoV-2 infection in central and north Texas and impact on other circulating respiratory viruses.
    Mutnal MB; Arroliga AC; Walker K; Mohammad A; Brigmon MM; Beaver RM; Midturi JK; Rao A
    J Med Virol; 2020 Oct; 92(10):2130-2138. PubMed ID: 32410236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anesthetic Complications Associated With Severe Acute Respiratory Syndrome Coronavirus 2 in Pediatric Patients.
    Saynhalath R; Alex G; Efune PN; Szmuk P; Zhu H; Sanford EL
    Anesth Analg; 2021 Aug; 133(2):483-490. PubMed ID: 33886516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community Coronavirus Disease 2019 Activity Level and Nursing Home Staff Testing for Active Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Indiana.
    Blackburn J; Weaver L; Cohen L; Menachemi N; Rusyniak DE; Unroe KT
    J Am Med Dir Assoc; 2021 Jan; 22(1):204-208.e1. PubMed ID: 33248030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asymptomatic Healthcare Worker PCR Screening during SARS-CoV-2 Omicron Surge, Germany, 2022.
    Bertram R; Hitzl W; Steinmann E; Steinmann J
    Emerg Infect Dis; 2023 Aug; 29(8):1690-1692. PubMed ID: 37352551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low Incidence of Asymptomatic Positive Patients Detected During Preoperative Testing for Total Joint Arthroplasty During the COVID-19 Pandemic.
    Zangrilli J; Hameed D; Chisari E; Vannello C; Courtney PM; Krueger CA
    J Am Acad Orthop Surg; 2021 Dec; 29(23):e1217-e1224. PubMed ID: 33539060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protocol for a winter sentinel surveillance program of notifiable respiratory viruses in Queensland.
    Ginige S; Firman E; Li YS; Soonarane Y; Smoll N; May F; Hunter I; Pery B; Macfarlane B; Bladen T; Allen T; Lennon M; Walker J; Slinko V; Stickley M; Khandaker G; Anuradha S; Wattiaux A
    PLoS One; 2022; 17(11):e0277895. PubMed ID: 36441699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of 135 794 Pediatric Patients Tested for Severe Acute Respiratory Syndrome Coronavirus 2 Across the United States.
    Bailey LC; Razzaghi H; Burrows EK; Bunnell HT; Camacho PEF; Christakis DA; Eckrich D; Kitzmiller M; Lin SM; Magnusen BC; Newland J; Pajor NM; Ranade D; Rao S; Sofela O; Zahner J; Bruno C; Forrest CB
    JAMA Pediatr; 2021 Feb; 175(2):176-184. PubMed ID: 33226415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of the Respiratory Viral Panel PCR Test Results Before and After COVID-19 Pandemic].
    Alp A; Taşçı O; Ergin A; Köseoğlu Eser Ö
    Mikrobiyol Bul; 2022 Oct; 56(4):667-681. PubMed ID: 36458713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic Performance of Self-Collected Saliva Versus Nasopharyngeal Swab for the Molecular Detection of SARS-CoV-2 in the Clinical Setting.
    Uddin MKM; Shirin T; Hossain ME; Alam AN; Ami JQ; Hasan R; Miah M; Shaly NJ; Ahmed S; Rahman SMM; Rahman M; Banu S
    Microbiol Spectr; 2021 Dec; 9(3):e0046821. PubMed ID: 34730436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in Detention Facility, Louisiana, USA, May-June, 2020.
    Wallace M; James AE; Silver R; Koh M; Tobolowsky FA; Simonson S; Gold JAW; Fukunaga R; Njuguna H; Bordelon K; Wortham J; Coughlin M; Harcourt JL; Tamin A; Whitaker B; Thornburg NJ; Tao Y; Queen K; Uehara A; Paden CR; Zhang J; Tong S; Haydel D; Tran H; Kim K; Fisher KA; Marlow M; Tate JE; Doshi RH; Sokol T; Curran KG
    Emerg Infect Dis; 2021 Feb; 27(2):421-429. PubMed ID: 33395380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of severe acute respiratory syndrome coronavirus 2 infection among women with polycystic ovary syndrome.
    Alur-Gupta S; Boland MR; Dokras A;
    Fertil Steril; 2023 May; 119(5):847-857. PubMed ID: 36693555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Frequent SARS-CoV-2 Testing on Weekly Case Rates in Long-Term Care Facilities, Florida, USA.
    Allan-Blitz LT; Aboabdo B; Turner I; Klausner JD
    Emerg Infect Dis; 2022 Sep; 28(9):1918-1920. PubMed ID: 35914517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Universal admission laboratory screening for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) asymptomatic infection across a large health system.
    Cihlar JL; Harris BD; Wright PW; Humphries RM; Taylor CK; Cherry BR; Talbot TR
    Infect Control Hosp Epidemiol; 2023 Jan; 44(1):68-74. PubMed ID: 36533305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral Infections of the Upper Airway in the Setting of COVID-19: A Primer for Rhinologists.
    Yuen E; Gudis DA; Rowan NR; Nguyen SA; Schlosser RJ
    Am J Rhinol Allergy; 2021 Jan; 35(1):122-131. PubMed ID: 32762250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.